Dermatology Department, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Clin Exp Dermatol. 2018 Jul;43(5):589-591. doi: 10.1111/ced.13422. Epub 2018 Feb 20.
Naevus sebaceous (NS) is a congenital cutaneous hamartoma, which typically occurs on the head and neck. Historically, the treatment of choice was excision in infancy because of the potential for malignant transformation; however, recent studies suggest that this risk is < 1% and unlikely in childhood. We sent a questionnaire to UK dermatologists and plastic surgeons to investigate current management practice of NS. We found that almost a third of dermatologists still recommend excision for malignancy prevention, while over 90% of plastic surgeons consider excision, with 64% citing malignancy prevention as the reason. Plastic surgeons most commonly recommended excision in childhood, whereas dermatologists waited until adulthood. We have shown there is significant variation in practice across the UK in the management of naevus NS. It is important that patients across the UK receive the same standard of care, and therefore we advocate the development of evidence-based guidance for treatment of naevus NS.
皮脂腺痣 (NS) 是一种先天性皮肤错构瘤,通常发生在头部和颈部。历史上,由于有恶性转化的潜在风险,选择的治疗方法是在婴儿期切除;然而,最近的研究表明这种风险 < 1%,并且在儿童期不太可能发生。我们向英国皮肤科医生和整形外科医生发送了一份问卷,以调查 NS 的当前管理实践。我们发现,近三分之一的皮肤科医生仍建议切除以预防恶性肿瘤,而超过 90%的整形外科医生认为切除是必要的,其中 64%的人将预防恶性肿瘤作为原因。整形外科医生最常建议在儿童期切除,而皮肤科医生则等到成年后。我们已经表明,在英国,NS 皮脂腺痣的管理实践存在显著差异。重要的是,英国各地的患者都能得到相同的护理标准,因此我们主张制定基于证据的 NS 皮脂腺痣治疗指南。